The Promise of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders by Samantha Wilkinson, Elaine A. Moore

The Promise of Low Dose Naltrexone Therapy: Potential Benefits in Cancer, Autoimmune, Neurological and Infectious Disorders

McFarland Health Topics

Samantha Wilkinson, Elaine A. Moore

213 pages • missing pub info (editions)

nonfiction health challenging informative medium-paced
Powered by AI (Beta)
Loading...

Description

Naltrexone is an opiate antagonist drug developed in the 1970s and approved by the FDA in 1984 for opiate and drug abuse treatment. When used at much lower doses in an off-label protocol referred to as low dose naltrexone (LDN), the drug has been ...

Read more

Community Reviews

Loading...

Content Warnings

Loading...